Jones Trading Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $16
Jones Trading analyst Debanjana Chatterjee initiates coverage on Alterity Therapeutics (NASDAQ: ATHE ) with a Buy rating and announces Price Target of $16.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.